E-Poster Presentations
- AS01 CLINICAL TRIAL RESULTS – ACUTE MANAGEMENT – NEITHER THROMBOLYSIS NOR THROMBECTOMY
- AS02 CLINICAL TRIAL RESULTS – ACUTE MANAGEMENT – THROMBOLYSIS OR THROMBECTOMY
- AS03 CLINICAL TRIAL RESULTS – PREVENTION
- AS04 CLINICAL TRIAL RESULTS – REHABILITATION & RECOVERY
- AS05 THROMBOLYSIS – EXCLUDING CLINICAL TRIAL RESULTS
- AS06 HYPERACUTE MANAGEMENT – EXCLUDING CLINICAL TRIAL RESULTS
- AS07 NEUROINTERVENTION – EXCLUDING CLINICAL TRIAL RESULTS
- AS08 REHABILITATION – EXCLUDING CLINICAL TRIAL RESULTS
- AS09 RISK FACTORS AND PREVENTION
- AS10 SECONDARY PREVENTION – EXCLUDING CLINICAL TRIAL RESULTS
- AS11 IMAGING – HYPERACUTE
- AS12 IMAGING – NON ACUTE INCLUDING NEUROSONOLOGY
- AS13 SERVICE ORGANISATION/QUALITY IMPROVEMENT
- AS14 CLINICAL PRACTICE, MANAGEMENT AND CARE
- AS15 DIAGNOSIS/INVESTIGATION OF STROKE ETIOLOGY
- AS16 PROGNOSIS AND OUTCOME AFTER STROKE
- AS17 STROKE COMPLICATIONS
- AS18 PATHOPHYSIOLOGY OF STROKE
- AS19 BRAIN REORGANISATION AND RECOVERY
- AS20 LARGE ARTERY ATHEROSCLEROSIS - INCLUDING INTRACRANIAL STENOSIS
- AS21 RARE CAUSES, STROKE IN THE YOUNG
- AS22 INTRACEREBRAL HAEMORRHAGE
- AS23 ATRIAL FIBRILLATION, CARDIOEMBOLISM & HEART-BRAIN INTERACTIONS
- AS24 COGNITION AND VASCULAR COGNITIVE IMPAIRMENT
- AS25 SMALL VESSEL DISEASE
- AS26 SAH, ANEURYSMS AND VASCULAR MALFORMATIONS
- AS27 TIA
- AS28 SEX, GENDER AND STROKE PREVENTION, TREATMENT, AND RECOVERY
- AS30 EXPERIMENTAL/TRANSLATIONAL MEDICINE
- AS31 GENETICS, ‘OMICS AND BIOMARKERS
- AS32 SYSTEMATIC REVIEW AND META-ANALYSIS
- AS34 CEREBROVASCULAR MANIFESTATIONS OF COVID-19 AND OTHER INFECTIONS
- AS35 TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE